Indo Us Biotech shareholders and shareholding pattern
NSE: INDOUSBSE: 541304Agricultural Food & other ProductsSmall Cap
Indo Us Biotech Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 2018 on BSE, Sep 2024 on NSE
Last close ₹86.84up ₹14.47 (19.99%)BSE ₹86.42
Share price at the NSE close on 28 Oct 2026. Previous close ₹72.37.
28 Oct: open ₹83.00, high ₹86.84, low ₹80.35
52-week range of traded prices to 28 Oct 2026
₹57.50Low, 26 Oct 2026₹159.00High, 27 Nov 2025
- Next results date: the board meets on 30 Oct 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹174 Cr2,332nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 15.20
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.88
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 13.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 11.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.40
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 3,05,46733.5% delivered
Indo Us Biotech's shareholding pattern for Sep 2026, filed on 14 Oct 2026, with every filing from Jun 2018: who owns its shares by group, its promoters by name and its public holders of 1% or more.
Who owns Indo Us Biotech, filing by filing
Per cent of the company's shares.
Sep 2026 filing
- Promoters68.29%
- Foreign institutions0.01%
- Indian institutions0.25%
- Individuals and others31.45%
Shareholding pattern, per cent, from Jun 2018
- Promoters
- Foreign institutions
- Indian institutions
- Individuals and others
| Per cent | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Sep 2020 | Dec 2020 | Jun 2021 | Sep 2021 | Dec 2021 | Jun 2022 | Sep 2022 | Dec 2022 | Jun 2023 | Sep 2023 | Dec 2023 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 70.54% | 70.54% | 70.54% | 70.54% | 70.54% | 70.54% | 70.54% | 72.19% | 73.01% | 73.01% | 73.01% | 73.01% | 73.01% | 74.02% | 70.17% | 70.17% | 70.17% | 70.17% | 70.17% | 70.17% | 70.17% | 70.17% | 70.17% | 70.17% | 70.17% | 68.29% | 68.29% | 68.29% | |
| Indian promoters | 70.54% | 70.54% | 70.54% | 70.54% | 70.54% | 70.54% | 70.54% | 72.19% | 73.01% | 73.01% | 73.01% | 73.01% | 73.01% | 74.02% | 70.17% | 70.17% | 70.17% | 70.17% | 70.17% | 70.17% | 70.17% | 70.17% | 70.17% | 70.17% | 70.17% | 68.29% | 68.29% | 68.29% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. Public in the glossary | 29.46% | 29.46% | 29.46% | 29.46% | 29.46% | 29.46% | 29.46% | 27.81% | 26.99% | 26.99% | 26.99% | 26.99% | 26.99% | 25.98% | 29.83% | 29.83% | 29.83% | 29.83% | 29.83% | 29.83% | 29.83% | 29.83% | 29.83% | 29.83% | 29.83% | 31.71% | 31.71% | 31.71% |
| Shares in issue | 48,54,392 | 48,54,392 | 48,54,392 | 48,54,392 | 60,67,990 | 60,67,990 | 60,67,990 | 60,67,990 | 60,67,990 | 60,67,990 | 60,67,990 | 72,81,588 | 72,81,588 | 91,66,700 | 1,00,26,000 | 1,00,26,000 | 2,00,52,000 | 2,00,52,000 | 2,00,52,000 | 2,00,52,000 | 2,00,52,000 | 2,00,52,000 | 2,00,52,000 | 2,00,52,000 | 2,00,52,000 | 2,00,52,000 | 2,00,52,000 | 2,00,52,000 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. Shares locked in in the glossary | 34,24,392 | 34,24,392 | 34,24,392 | 34,24,392 | 12,20,000 | 12,20,000 | 12,20,000 | 12,20,000 | 12,20,000 | – | – | 1,80,014 | 0 | 73,63,649 | 82,22,949 | 17,18,412 | 34,36,824 | 34,36,824 | 34,36,824 | 29,36,824 | 29,36,824 | 29,36,824 | 29,36,824 | 29,36,824 | – | – | – | – |
| Promoters' shares locked in | 34,24,352 | 34,24,352 | 34,24,352 | 34,24,352 | 12,20,000 | 12,20,000 | 12,20,000 | 12,20,000 | 12,20,000 | – | – | 1,80,014 | 0 | 67,84,949 | 70,34,949 | 17,18,412 | 34,36,824 | 34,36,824 | 34,36,824 | 29,36,824 | 29,36,824 | 29,36,824 | 29,36,824 | 29,36,824 | – | – | – | – |
A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.
Indo Us Biotech promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is JAGDISHKUMAR DEVJIBHAI AJUDIYA, 48.82%.Promoter buying and selling
| Holder | ||
|---|---|---|
| JAGDISHKUMAR DEVJIBHAI AJUDIYAIndividuals and Hindu undivided families | 48.82% | 97,88,924 |
| INDO-US AGRISEEDS LIMITEDIndian companies, trusts and others | 8.82% | 17,69,569 |
| AJUDIA JAGDISH DEVJIBHAI HUFIndividuals and Hindu undivided families | 5.74% | 11,50,028 |
| MALTI JAGDISHBHAI AJUDIAIndividuals and Hindu undivided families | 2.91% | 5,84,122 |
| PRIYANKA SAMARTH PATELIndividuals and Hindu undivided families | 1.99% | 4,00,000 |
| SAMARTH NILESHBHAI PATELIndividuals and Hindu undivided families | 0.00% | 500 |
| HINABEN NILESHBHAI PATELIndividuals and Hindu undivided families | 0.00% | 500 |
No promoter shares are reported as pledged.
Largest public holders of Indo Us Biotech, filing by filing
Per cent, on the same shares as the split above.
| Holder | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Sep 2020 | Dec 2020 | Jun 2021 | Sep 2021 | Dec 2021 | Jun 2022 | Sep 2022 | Dec 2022 | Jun 2023 | Sep 2023 | Dec 2023 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IMPROWISED TECHNOLOGIES PRIVATECompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.99% | 1.99% | 1.99% | 1.99% | 1.99% | 1.99% | 1.99% | 1.99% | 1.99% | 1.99% | 1.99% | 1.99% | 1.99% | 1.99% |
| BHARTIBEN RAJENDRA GANDHIResident individuals, over ₹2 lakh at face value | 1.03% | 1.52% | 2.06% | 2.06% | 2.06% | 1.24% | 1.24% | 1.24% | 1.24% | 1.24% | 1.24% | 1.24% | 1.24% | – | – | – | – | – | – | – | – | – | – | 1.65% | 1.65% | 1.50% | 1.50% | 1.50% |
| PRATIK RAJENDRABHAI GANDHIResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.64% | – | 1.50% | 1.50% | 1.50% | 1.50% | 1.50% | 1.50% | 1.50% | 1.50% | 1.50% | 1.50% | 1.50% | 1.50% | 1.50% |
| AUMIT CAPITAL ADVISORS LIMITEDCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.15% | 1.05% | 1.12% | 1.11% | 1.08% | 1.08% | 1.18% | 1.18% | 1.20% | 1.20% | 1.20% | 1.20% | 1.19% | 1.19% | 1.19% |
| NATVARSINH T CHAVDA .Resident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | 1.57% | 1.52% | 1.52% | 1.52% | 1.21% | 1.11% | 1.11% | 1.11% | 1.11% | 1.10% | 1.10% | 1.05% | 1.02% | 1.02% | 1.02% | 1.02% | 1.02% | 1.02% | 1.07% |
| NITIN DALPATLAL SHAHResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.70% | 1.65% | 1.65% | 1.65% | 1.65% | 1.06% | 1.06% | 1.06% | 1.06% | 1.06% | – | – | – | – | – |
| MANISHA NITINKUMAR SHAHResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.52% | 1.39% | 1.43% | 1.43% | 1.43% | – | – | – | – | – | – | – | – | – | – |
| HIMANSHU CHINUBHAI SHAHResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.11% | 1.01% | 1.01% | 1.01% | 1.01% | – | – | – | – | – | – | – | – | – | – |
| PRATIK RAJENDRA GANDHIResident individuals, over ₹2 lakh at face value | 1.03% | 1.03% | 1.03% | 1.03% | 1.03% | 2.06% | 2.06% | 2.06% | 2.06% | 2.06% | 2.06% | 2.06% | 2.06% | – | 1.50% | – | – | – | – | – | – | – | – | – | – | – | – | – |
| SHALIN SHAH .Resident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.01% | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| MADHUBEN DHIRAJLAL GANDHIResident individuals, over ₹2 lakh at face value | 1.03% | 1.03% | 1.03% | 1.03% | 1.03% | 1.03% | 1.03% | 1.03% | 1.03% | 1.03% | 1.03% | 1.03% | 1.03% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| VIPUL RAJENDRABHAI GANDHIResident individuals, over ₹2 lakh at face value | 1.03% | 1.03% | 1.03% | 1.03% | 1.03% | 1.03% | 1.03% | 1.03% | 1.03% | 1.03% | 1.03% | 1.03% | 1.03% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| GANDHI RAJENDRA DHIRAJLALOther non-institutions | – | – | – | – | 1.03% | – | – | 1.03% | 1.03% | 1.03% | 1.03% | 1.03% | 1.03% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| SARLABEN JAYESHKUMAR SHAHResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | 1.19% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| TEJAS ROHITKUMAR SHAHResident individuals, over ₹2 lakh at face value | – | – | – | – | – | 2.05% | 1.52% | 1.13% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| SUSHIL FINANCIAL SERVICES PVT. LTD.Other non-institutions | – | – | – | – | – | 1.56% | 1.61% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| JAYESHKUMAR WAGHJIBHAI SHAHResident individuals, over ₹2 lakh at face value | 1.36% | 1.36% | 1.36% | 1.36% | 1.36% | 1.19% | 1.19% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| RAJENDRA DHIRAJLAL GANDHI HUFResident individuals, over ₹2 lakh at face value | 1.03% | 1.03% | 1.03% | 1.03% | – | 1.03% | 1.03% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| ZERODHA BROKING LTD.Other non-institutions | – | – | – | – | – | 1.03% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| RAJENDRA DHIRAJLAL GANDHIResident individuals, over ₹2 lakh at face value | 1.03% | 1.03% | 1.03% | 1.03% | 1.03% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| RAMESHBHAI S DOMADIYAResident individuals, over ₹2 lakh at face value | 1.24% | 1.24% | 1.24% | 1.03% | 1.03% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| PRATIK RAJENDRA GANDHI (HUF)Resident individuals, over ₹2 lakh at face value | – | 1.03% | 1.03% | 1.03% | 1.03% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| DEVENDRA RAMNIKLAL MANDALIYAResident individuals, over ₹2 lakh at face value | – | 1.24% | 1.19% | 1.03% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| NEHALBEN CHANDUBHAI KUMBHANIResident individuals, over ₹2 lakh at face value | 1.24% | 1.24% | 1.24% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| CHIRAGKUMAR PRABHUDAS PATELResident individuals, over ₹2 lakh at face value | – | – | 1.15% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| SHARDABEN CHANDUBHAI KUMBHANIResident individuals, over ₹2 lakh at face value | 1.11% | 1.11% | 1.11% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| BEELINE BROKING LIMITEDOther non-institutions | 2.51% | 2.51% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent.
Who moved in the Sep 2026 filing
Against the Jun 2026 filing. A filing names a public holder only at 1% or more, so a holder no longer named fell under 1% or sold out.
- Individuals and others: NATVARSINH T CHAVDA . 1.07%, +0.05 pts